Comment on: "CYP3A4*22 Genotype‑Guided Dosing of Kinase Inhibitors in Cancer Patients"

Thijs H Oude Munnink; Saskia K Klein; Daan J Touw

doi:10.1007/s40262-024-01380-5

Comment on: "CYP3A4*22 Genotype‑Guided Dosing of Kinase Inhibitors in Cancer Patients"

Thijs H Oude Munnink^*, Saskia K Klein, Daan J Touw

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

48 Downloads (Pure)

Original language	English
Pages (from-to)	917–918
Number of pages	2
Journal	Clinical Pharmacokinetics
Volume	63
Early online date	11-May-2024
DOIs	https://doi.org/10.1007/s40262-024-01380-5
Publication status	Published - Jun-2024

Access to Document

10.1007/s40262-024-01380-5

Comment on: “CYP3A4*22 Genotype‑Guided Dosing of Kinase Inhibitors in Cancer Patients”Final publisher's version, 318 KBLicence: Taverne

Handle.net

Persistent link

1 Article

CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients
the Dutch Pharmacology Oncology Group, van Eerden, R. A. G., IJzerman, N. S., van Meekeren, M., Oomen-de Hoop, E., Guchelaar, N. A. D., Visser, A. M. W., Matic, M., van Schaik, R. H. N., de Bruijn, P., Moes, D. J. A. R., Jobse, P. A., Gelderblom, H., Huitema, A. D. R., Steeghs, N., Mathijssen, R. H. J. & Koolen, S. L. W., 13-Jun-2023, In: Clinical Pharmacokinetics. 62, 8, p. 1129-1139 11 p.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access
File
6 Citations (Scopus)

10 Downloads (Pure)

Cite this

@article{e9c6726792eb48429dc8a4e51fe3ded9,

title = "Comment on: {"}CYP3A4*22 Genotype‑Guided Dosing of Kinase Inhibitors in Cancer Patients{"}",

author = "\{Oude Munnink\}, \{Thijs H\} and Klein, \{Saskia K\} and Touw, \{Daan J\}",

year = "2024",

month = jun,

doi = "10.1007/s40262-024-01380-5",

language = "English",

volume = "63",

pages = "917–918",

journal = "Clinical Pharmacokinetics",

issn = "0312-5963",

publisher = "Springer International Publishing AG",

}

TY - JOUR

T1 - Comment on: "CYP3A4*22 Genotype‑Guided Dosing of Kinase Inhibitors in Cancer Patients"

AU - Oude Munnink, Thijs H

AU - Klein, Saskia K

AU - Touw, Daan J

PY - 2024/6

Y1 - 2024/6

U2 - 10.1007/s40262-024-01380-5

DO - 10.1007/s40262-024-01380-5

M3 - Comment/Letter to the editor

C2 - 38734861

SN - 0312-5963

VL - 63

SP - 917

EP - 918

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

ER -

Comment on: "CYP3A4*22 Genotype‑Guided Dosing of Kinase Inhibitors in Cancer Patients"

Access to Document

Handle.net

Research output

CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients

Cite this